# EDGAR Filing Document

**Accession Number:** 0001826667
**File Stem:** 0001826667-25-000137
**Filing Date:** 2025-12
**Character Count:** 2343
**Document Hash:** 304b21e1c4d282a0b72f07cf8f21a369
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001826667-25-000137.hdr.sgml**: 20260420

**ACCESSION NUMBER**: 0001826667-25-000137

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TriSalus Life Sciences, Inc.
- **CENTRAL INDEX KEY:** 0001826667
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 853009869
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 6272 WEST 91ST AVENUE
- **CITY:** WESTMINSTER
- **STATE:** CO
- **ZIP:** 80031
- **BUSINESS PHONE:** 415 336 8917

**MAIL ADDRESS:**
- **STREET 1:** 6272 WEST 91ST AVENUE
- **CITY:** WESTMINSTER
- **STATE:** CO
- **ZIP:** 80031

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MedTech Acquisition Corp
- **DATE OF NAME CHANGE:** 20200930

**TRISALUS LIFE SCIENCES, INC.**

6272 W. 91<sup>st</sup>. Ave.

Westminster, Colorado 80031

December 2, 2025

---

| | |
|:---|:---|
| **<u>VIA EDGAR</u>** | **<u>VIA EDGAR</u>** |
| United States Securities and Exchange Commission | United States Securities and Exchange Commission |
| 100 F Street, N.E. | 100 F Street, N.E. |
| Washington, D.C. 20549 | Washington, D.C. 20549 |
| Attention: Nick O'Leary | Attention: Nick O'Leary |
| **Re:** | **TriSalus Life Sciences, Inc.** |
| | **Registration Statement on Form S-3** |
| | **File No. 333-291509** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, TriSalus Life Sciences, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Time, on Thursday, December 4, 2025, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Registrant, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

TRISALUS LIFE SCIENCES, INC.

By: *<u>/s/ Mary Szela</u>* 

Name: Mary Szela

Title: Chief Executive Officer

<br>